Previous 10 | Next 10 |
Gainers: Sonoma Pharmaceuticals (SNOA) +114%. NantHealth (NH) +110%. vTv Therapeutics (VTVT) +59%. aTyr Pharma (LIFE) +33%. NantKwest (NK) +22%.Losers: SELLAS Life Sciences (SLS) -33%. Immutep (IMMP) -29%. Salarius Pharmaceuticals (SLRX) -29%. Nabriva Therapeutics (NBRV) -29%. ALX O...
Sonoma Pharmaceuticals (SNOA) +35.3% post-market after announcing a partnership with Crown Laboratories for a license and supply agreement for exclusive rights to sell and market products for the over-the-counter dermatological market in the U.S.Under the deal terms, Crown will sell Sonoma's ...
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing high performance stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, oral care, nasal care and dermatological conditions, and Crown...
Sonoma Pharmaceuticals (SNOA): FQ2 GAAP EPS of $0.07.Revenue of $5.77M (+22.0% Y/Y)Shares +5.58%.Press Release For further details see: Sonoma Pharmaceuticals reports FQ2 results
Revenues of $5.8 and $11.5 million increased by 22% for the quarter and 25% for the six months ended September 30, 2020 due to strong international growth Operating Expenses continue to trend down by 33% for second quarter 2021 versus second quarter 2020 Net income p...
Gainers: Phoenix Tree (DNK) +91%.Naked Brand (NAKD) +64%.Kazia Therapeutics (KZIA) +32%.Micro Focus International (MFGP) +32%.BELLUS Health (BLU) +31%.InnSuites Hospitality Trust (IHT) +27%.FuelCell Energy (FCEL) +27%.Ashford Hospitality Trust (AHT) +24%.CIIG Merger (CIIC) ...
Cassava Sciences (NASDAQ: SAVA ) +27% on insider buying. More news on: Cassava Sciences, Inc., Immutep Limited, ClearOne, Inc., , Stocks on the move, Read more ...
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, oral care, nasal care and dermatological conditions, and its partner, the MicroSafe G...
Sonoma Pharmaceuticals (NASDAQ: SNOA ) and partner, Te Arai BioFarma have launched two new products - Nasocyn Nasal Care and Oracyn Oral Care in Australia. More news on: Sonoma Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Yield10 Bioscience (NASDAQ: YTEN ) +81% . More news on: Yield10 Bioscience, Inc., Virtusa Corporation, RH, Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Sonoma Pharmaceuticals Inc. Company Name:
SNOA Stock Symbol:
NASDAQ Market:
Sonoma Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 46.5% to $0.2183 on volume of 404,016,812 shares NVIDIA Corporation (NVDA) rose 2.6% to $121.09 on volume of 317,123,916 shares PROSHARES TRUST (SQQQ) rose 1.5% to $8.23 on volume of 207,449,647 shares Max...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...
BOULDER, CO / ACCESSWIRE / July 9, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn ® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and ...